Mackay Shields LLC’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-11,700
Closed -$191K 1554
2020
Q3
$191K Buy
+11,700
New +$218K ﹤0.01% 1339
2020
Q2
Sell
-41,098
Closed -$478K 1534
2020
Q1
$478K Sell
41,098
-159,031
-79% -$3.28M ﹤0.01% 1138
2019
Q4
$5.56M Buy
200,129
+103,150
+106% +$2.59M 0.04% 441
2019
Q3
$2.19M Buy
+96,979
New +$2.21M 0.01% 859
2018
Q4
Sell
-67,317
Closed -$3.14M 1388
2018
Q3
$3.14M Buy
67,317
+11,191
+20% +$514K 0.02% 578
2018
Q2
$2.43M Buy
56,126
+25,364
+82% +$1.22M 0.02% 711
2018
Q1
$1.71M Buy
+30,762
New +$1.69M 0.01% 832

Other funds holding MD

Mackay Shields LLC's MD Position: Q4 2020 in Review

Mackay Shields LLC sold out of Pediatrix Medical (MD) in Q4 2020, closing a stake of 11,700 shares — an estimated $191K sold.

Mackay Shields LLC first reported a position in MD in Q1 2018 and held it in 7 quarters. The position peaked at $5.56M in Q4 2019. 201 funds tracked by Wall St. Rank hold MD as of Q4 2020.

  • Mackay Shields LLC reported no remaining Pediatrix Medical position as of Q4 2020 after selling out during the quarter.
  • Mackay Shields LLC sold 11,700 Pediatrix Medical shares in Q4 2020, an estimated $191K.
  • Mackay Shields LLC first reported a position in Pediatrix Medical in Q1 2018 and held it in 7 quarters.
  • Mackay Shields LLC's Pediatrix Medical position peaked at $5.56M in Q4 2019.
  • 201 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2020.

Based on Mackay Shields LLC's 13F filing for Q4 2020, filed 16 Feb 2021.